[Adjuvant therapy during the administration of GnRH agonists]

A Nikolov, Nikolov A, G Kolarov, Kolarov G
Akusherstvo i ginekologiia · 2002 · vol. 41(2) , pp. 36–40 · PMID:12066551
Review public-domain-us
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-10 ⓘ

The paper discusses the use of adjuvant therapy administered alongside gonadotropin-releasing hormone agonists, though no specific findings or clinical outcomes are detailed in the available text.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adjuvants, Pharmaceutic Antineoplastic Agents, Hormonal Gonadotropin-Releasing Hormone Goserelin Adjuvants, Pharmaceutic Adjuvants, Pharmaceutic Adult Adult Antineoplastic Agents, Hormonal Antineoplastic Agents, Hormonal Drug Therapy, Combination Drug Therapy, Combination Endometriosis Endometriosis Endometriosis Female Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
pubmed
last seen: 2026-10-08T21:00:31.392641+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine